Endothelial protein C receptor (EPCR) also known asactivated protein C receptor (APC receptor) is aprotein that in humans is encoded by thePROCRgene.[5][6][7] PROCR has also recently been designatedCD201 (cluster of differentiation 201).
EPCR is a transmembrane glycoprotein receptor that plays a crucial role in regulation of blood coagulation, inflammation, and vascular integrity. Its ability to enhance the anticoagulant activity of protein C, modulate inflammatory responses, and maintain endothelial barrier function highlights its importance in homeostasis maintenance.[8]
EPCR protein is an N-glycosylated type I membrane protein that enhances the activation of protein C.[7] It belongs to theMHC class I/CD1 family of proteins, The structure of CD201 consists of an extracellular domain, a transmembrane domain, and a cytoplasmic tail. The extracellular domain of CD201 contains a high-affinity binding site for activated protein C (APC), a serine protease with anticoagulant properties.[8] The binding site for APC resembles a deep groove with a lipid inside. The bound lipid in EPCR is usually phosphatidylcholine or phosphatidylethanolamine, and it contributes to APC binding[9]
CD201 is expressed on the surface of endothelial cells, which form the inner lining of blood vessels. CD201 has also been identified as hematopoietic stem cell (HSC) marker.[10][11]
The main function of CD201 is to enhance the activation of protein C. The binding of APC to EPCR on the endothelial cell surface facilitates its anticoagulant activity by inhibiting factors Va and VIIIa. Apart from its anticoagulant role, CD201 also participates in an anti-inflammatory signaling. CD201 has been shown to affect the production of inflammatory cytokines upon binding a coagulation factor VIIa.[12]
CD201 is gaining recognition as a marker in patients with acute infections as well as in patients with vascular diseases. Recently, CD201 has been studied in relationship with rheumatoid arthritis.
In a recent study on emergency granulopoiesis, it has been observed that CD201 is highly expressed on lymphoid-biased HSCs under steady-state conditions. However, during emergency granulopoiesis, the loss of CD201 marked a transcriptional switch from a lymphoid to a myeloid identity in HSCs. These findings suggest that CD201 is involved in the regulation of the response to acute infection.[13] As with many signaling molecules, the context of their effect matters. It has been mentioned above that CD201 has anti-inflammatory properties during coagulation. However, in a rheumatoid arthritis (RA) murine model it has been shown that CD201 knock-out (KO) mice had 40% lower arthritis incidence and 50% less disease severity compared to wild-type (WT) mice. CD201 KO mice also had significantly fewer Th1/Th17 cells in synovial tissues, which implies that CD201 may play a role in the regulation of immune cell populations involved in the pathogenesis of RA.[14]
The importance of CD201 as a clinical marker has been demonstrated in another study where decreased patient serum levels of CD201 have been associated with vascular dysfunctions.[15]
Van de Wouwer M, Collen D, Conway EM (August 2004). "Thrombomodulin-protein C-EPCR system: integrated to regulate coagulation and inflammation".Arteriosclerosis, Thrombosis, and Vascular Biology.24 (8):1374–1383.doi:10.1161/01.ATV.0000134298.25489.92.PMID15178554.
Medina P, Navarro S, Estellés A, España F (September 2007). "Polymorphisms in the endothelial protein C receptor gene and thrombophilia".Thrombosis and Haemostasis.98 (3):564–569.doi:10.1160/th07-01-0071.PMID17849044.S2CID3646665.
Laszik Z, Mitro A, Taylor FB, Ferrell G, Esmon CT (November 1997). "Human protein C receptor is present primarily on endothelium of large blood vessels: implications for the control of the protein C pathway".Circulation.96 (10):3633–3640.doi:10.1161/01.cir.96.10.3633.PMID9396465.
Ye X, Fukudome K, Tsuneyoshi N, Satoh T, Tokunaga O, Sugawara K, et al. (June 1999). "The endothelial cell protein C receptor (EPCR) functions as a primary receptor for protein C activation on endothelial cells in arteries, veins, and capillaries".Biochemical and Biophysical Research Communications.259 (3):671–677.Bibcode:1999BBRC..259..671Y.doi:10.1006/bbrc.1999.0846.PMID10364477.
Simmonds RE, Lane DA (July 1999). "Structural and functional implications of the intron/exon organization of the human endothelial cell protein C/activated protein C receptor (EPCR) gene: comparison with the structure of CD1/major histocompatibility complex alpha1 and alpha2 domains".Blood.94 (2):632–641.doi:10.1182/blood.V94.2.632.PMID10397730.
Hayashi T, Nakamura H, Okada A, Takebayashi S, Wakita T, Yuasa H, et al. (October 1999). "Organization and chromosomal localization of the human endothelial protein C receptor gene".Gene.238 (2):367–373.doi:10.1016/S0378-1119(99)00360-1.PMID10570964.
Biguzzi E, Merati G, Liaw PC, Bucciarelli P, Oganesyan N, Qu D, et al. (October 2001). "A 23bp insertion in the endothelial protein C receptor (EPCR) gene impairs EPCR function".Thrombosis and Haemostasis.86 (4):945–948.doi:10.1055/s-0037-1616515.PMID11686350.
Galligan L, Livingstone W, Volkov Y, Hokamp K, Murphy C, Lawler M, et al. (November 2001). "Characterization of protein C receptor expression in monocytes".British Journal of Haematology.115 (2):408–414.doi:10.1046/j.1365-2141.2001.03187.x.PMID11703343.S2CID6186108.
von Depka M, Czwalinna A, Eisert R, Wermes C, Scharrer I, Ganser A, et al. (December 2001). "Prevalence of a 23bp insertion in exon 3 of the endothelial cell protein C receptor gene in venous thrombophilia".Thrombosis and Haemostasis.86 (6):1360–1362.doi:10.1055/s-0037-1616735.PMID11776299.
